• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:ONNVF)

0.6180 UNCHANGED
Streaming Delayed Price Updated: 9:52 AM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about ONNVF

< Previous 1 2 3 Next >
NetworkNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) Advances ONC010 Manufacturing Process Development
June 10, 2026
Via Investor Brand Network
Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) Is ‘One to Watch’
June 10, 2026
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
June 09, 2026
Via ACCESS Newswire
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF)(Frankfurt: W1H) (WKN: A3EKSZ) Signs LOI to Advance ONC010 Development, Appoints VP of Corporate Finance
June 08, 2026
Via Investor Brand Network
News headline image
Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
June 05, 2026
Via ACCESS Newswire
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Advances Kilogram-Scale Manufacturing for ONC010 Program
June 03, 2026
Via Investor Brand Network
News headline image
Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
June 02, 2026
Via ACCESS Newswire
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF)(Frankfurt: W1H) (WKN: A3EKSZ) Advances Manufacturing Scale-Up for Lead Oncology Candidate ONC010
May 26, 2026
Via Investor Brand Network
News headline image
Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
May 19, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
May 15, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
May 12, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
May 08, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation
May 05, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
May 01, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program
April 28, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies
April 23, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Announces Completion of Analytical Method Development for Monomer Intermediate 1 Supporting ONC010 Program
April 21, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
April 17, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy
April 07, 2026
Via ACCESS Newswire
News headline image
OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI
April 01, 2026
From OneMedNet Corporation
Via GlobeNewswire
News headline image
Onco-Innovations Announces Closing of Private Placement
March 12, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Announces Amendment to Private Placement Pricing
February 12, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
February 04, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services
January 21, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Chairs Colorectal Cancer Canada Precision Oncology Forum Generating Roadmaps for the Next Era of Cancer Care
December 09, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
December 07, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Attends University of Alberta's 2025 Innovation Awards
November 25, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies
November 20, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development
November 18, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations' Inka Health Publishes Framework on Transportability of Real-World Evidence and Use in Health Technology Assessment
November 07, 2025
Via ACCESS Newswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap